Literature DB >> 17991612

Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice.

James A Lin1, Junji Watanabe, Nora Rozengurt, Ajay Narasimha, Martin G Martin, Jenny Wang, Jonathan Braun, Robert Langenbach, Srinivasa T Reddy.   

Abstract

Cyclooxygenases (COX) regulate a variety of inflammatory diseases, including inflammatory bowel disease (IBD). While the pathological effects of COX-1 inhibition by NSAIDs on intestinal ulceration are well established, the role of COX-2 on intestinal inflammation remains under investigation. In this paper, we report a protective role for COX-2 against diet-mediated intestinal inflammation in mice. COX-2(-/-) mice fed an atherogenic diet or diet containing cholate, but not chow or fat alone, had a high mortality whereas COX-1(-/-) mice and wild-type mice were unaffected by the dietary changes. Histological analysis identified the cause of death in COX-2(-/-) mice due to severe intestinal inflammation that was surprisingly limited to the ileo-ceco-colic junction. COX-2 expression is induced in the cecum of wild-type mice fed an atherogenic diet. Our findings show that COX-2 plays an anti-inflammatory role at the ileo-ceco-colic junction in mice, and the pathology of diet-mediated intestinal inflammation in COX-2(-/-) mice offers an excellent model system to elucidate the molecular mechanisms of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991612      PMCID: PMC2701900          DOI: 10.1016/j.prostaglandins.2007.04.004

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  47 in total

1.  Prostaglandin E2 increases growth and motility of colorectal carcinoma cells.

Authors:  H Sheng; J Shao; M K Washington; R N DuBois
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

2.  Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.

Authors:  M N Muscará; N Vergnolle; F Lovren; C R Triggle; S N Elliott; S Asfaha; J L Wallace
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing.

Authors:  M K Jones; H Wang; B M Peskar; E Levin; R M Itani; I J Sarfeh; A S Tarnawski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

4.  Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response.

Authors:  R D Newberry; J S McDonough; W F Stenson; R G Lorenz
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

Review 5.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

6.  Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1.

Authors:  B Glinghammar; H Inoue; J J Rafter
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

7.  The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.

Authors:  Kenji Kabashima; Tomomi Saji; Takahiko Murata; Miyako Nagamachi; Toshiyuki Matsuoka; Eri Segi; Kazuhito Tsuboi; Yukihiko Sugimoto; Takuya Kobayashi; Yoshiki Miyachi; Atsushi Ichikawa; Shuh Narumiya
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

8.  Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation.

Authors:  V Milovic; I C Teller; D Faust; W F Caspary; J Stein
Journal:  Eur J Clin Invest       Date:  2002-01       Impact factor: 4.686

9.  COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

Authors:  Gudmundur Sigthorsson; Robert J Simpson; Matthew Walley; Andrew Anthony; Russell Foster; Christoph Hotz-Behoftsitz; Abbas Palizban; Joaquim Pombo; Jo Watts; Scott G Morham; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.

Authors:  Ajay Narasimha; Junji Watanabe; James A Lin; Susan Hama; Robert Langenbach; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-03-14       Impact factor: 3.072

View more
  7 in total

1.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

2.  Atherogenic diets exacerbate colitis in mice deficient in glutathione peroxidase.

Authors:  Qiang Gao; R Steven Esworthy; Byung-Wook Kim; Timothy W Synold; David D Smith; Fong-Fong Chu
Journal:  Inflamm Bowel Dis       Date:  2010-12       Impact factor: 5.325

3.  G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity.

Authors:  Matthias R Meyer; Natalie C Fredette; Matthias Barton; Eric R Prossnitz
Journal:  J Endocrinol       Date:  2015-08-24       Impact factor: 4.286

4.  Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease.

Authors:  Junji Watanabe; James A Lin; Ajay J Narasimha; Ani Shahbazian; Tomo-O Ishikawa; Martin G Martin; Harvey R Herschman; Srinivasa T Reddy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

5.  Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.

Authors:  David Meriwether; Dawoud Sulaiman; Carmen Volpe; Anna Dorfman; Victor Grijalva; Nasrin Dorreh; R Sergio Solorzano-Vargas; Jifang Wang; Ellen O'Connor; Jeremy Papesh; Muriel Larauche; Hannah Trost; Mayakonda N Palgunachari; G M Anantharamaiah; Harvey R Herschman; Martin G Martin; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Clin Invest       Date:  2019-06-11       Impact factor: 19.456

6.  Regulation of Intestinal Inflammation by Dietary Fats.

Authors:  Abigail R Basson; Christy Chen; Filip Sagl; Ashley Trotter; Ilya Bederman; Adrian Gomez-Nguyen; Mark S Sundrud; Sanja Ilic; Fabio Cominelli; Alex Rodriguez-Palacios
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

7.  Shotgun cholanomics of ileal fluid.

Authors:  Yingjie Chen; Michael Ogundare; Christopher M Williams; Yuchen Wang; Yuqin Wang; Gavin W Sewell; Philip J Smith; Farooq Z Rahman; Nuala O'Shea; Anthony W Segal; William J Griffiths
Journal:  Biochimie       Date:  2012-09-14       Impact factor: 4.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.